EVAXION BIOTECH A/S (EVAX)
US29970R2040 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -22.13M | -23.17M | -24.53M | -15.02M | -11.20M | |||
| Depreciation Amortization | 615.00K | 570.00K | 340.00K | 110.00K | 80.00K | |||
| Change In Working Capital | 3.09M | -2.30M | 2.06M | 1.00M | 1.22M | |||
| Interest Paid | 65.00K | 170.00K | 30.00K | 30.00K | 40.00K | |||
| Other non cash items | 725.00K | -880.00K | 200.00K | 1.48M | 2.87M | |||
| OPERATING CASH FLOW | -17.69M | -25.77M | -21.93M | -12.44M | -7.03M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -87.00K | -290.00K | -1.36M | -180.00K | -60.00K | |||
| Other Investing Activity | -6.00K | 20.00K | 30.00K | -210.00K | N/A | |||
| INVESTING CASH FLOW | -93.00K | -270.00K | -1.33M | -390.00K | -60.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -632.00K | 7.43M | -290.00K | -70.00K | 80.00K | |||
| Stock Issued/Repurchased | 11.76M | 430.00K | 53.85M | 9.02M | 9.44M | |||
| Other Financing Activity | -432.00K | 0.00 | -3.76M | -130.00K | -10.00K | |||
| FINANCING CASH FLOW | 10.69M | 7.85M | 49.81M | 8.82M | 9.51M | |||
| Exchange Rate Effect | -508.00K | -790.00K | -210.00K | 290.00K | -300.00K | |||
| CHANGE IN CASH | -7.60M | -18.98M | 26.34M | -3.72M | 2.12M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.69M | -25.77M | -21.93M | -12.44M | -7.03M | |||
| Capital Expenditure | -87.00K | -290.00K | -1.36M | -180.00K | -60.00K | |||
| FREE CASH FLOW | -17.78M | -26.06M | -23.29M | -12.62M | -7.09M | |||
All data in USD